ENDP Endo International Plc

Endo International PLC is a generics and specialty branded pharmaceutical company. The company sells generic products in the US which includes pain management, urology, central nervous system disorders, immunosuppression, and oncology and among others.

$5.83  -0.22 (-3.64%)
As of 11/26/2021 13:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  Ireland
IPO date:  02/11/2013
Outstanding shares:  233,670,998
Average volume:  9,056,520
Market cap:   $1,413,709,538
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    G30401106
ISIN:        IE00BJ3V9050
Sedol:      BJ3V905
Valuation   (See tab for details)
PE ratio:   19.99
PB ratio:   -2.24
PS ratio:   0.48
Return on equity:   -9.87%
Net income %:   2.30%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy